Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005. Review.

PMID:
26194320
2.

Predictive Models Based on Support Vector Machines: Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer's Disease.

Retico A, Bosco P, Cerello P, Fiorina E, Chincarini A, Fantacci ME.

J Neuroimaging. 2015 Jul-Aug;25(4):552-63. doi: 10.1111/jon.12163. Epub 2014 Oct 7.

PMID:
25291354
3.

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Bertens D, Knol DL, Scheltens P, Visser PJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 May;11(5):511-22. doi: 10.1016/j.jalz.2014.05.1754. Epub 2014 Aug 20.

PMID:
25150730
4.

A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Braskie MN, Thompson PM.

Biol Psychiatry. 2014 Apr 1;75(7):527-33. doi: 10.1016/j.biopsych.2013.11.020. Epub 2013 Nov 28. Review.

5.

Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Braskie MN, Thompson PM.

Trends Cogn Sci. 2013 Oct;17(10):510-6. doi: 10.1016/j.tics.2013.08.007. Epub 2013 Sep 9. Review.

6.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. Review.

7.

Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study.

Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, DeCarli C, Jack CR Jr, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):174-81. doi: 10.1097/WAD.0b013e3182677b3d.

8.

Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.

Andrews KA, Modat M, Macdonald KE, Yeatman T, Cardoso MJ, Leung KK, Barnes J, Villemagne VL, Rowe CC, Fox NC, Ourselin S, Schott JM; Australian Imaging Biomarkers, Lifestyle Flagship Study of Ageing.

PLoS One. 2013;8(3):e58816. doi: 10.1371/journal.pone.0058816. Epub 2013 Mar 15.

9.

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.

Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 Aug;34(8):1996-2002. doi: 10.1016/j.neurobiolaging.2013.02.003. Epub 2013 Mar 21.

10.

Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.

Nho K, Risacher SL, Crane PK, DeCarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative--ADNI.

Brain Imaging Behav. 2012 Dec;6(4):551-67. doi: 10.1007/s11682-012-9203-2.

11.

Confirmatory factor analysis of the ADNI Neuropsychological Battery.

Park LQ, Gross AL, McLaren DG, Pa J, Johnson JK, Mitchell M, Manly JJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):528-39. doi: 10.1007/s11682-012-9190-3.

12.

The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.

Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J; ADNI investigators.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):168-73. doi: 10.1097/WAD.0b013e318260a79a.

13.

The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.

Skinner J, Carvalho JO, Potter GG, Thames A, Zelinski E, Crane PK, Gibbons LE; Alzheimer's Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):489-501. doi: 10.1007/s11682-012-9166-3.

14.

Brain structure and aging in chronic temporal lobe epilepsy.

Dabbs K, Becker T, Jones J, Rutecki P, Seidenberg M, Hermann B.

Epilepsia. 2012 Jun;53(6):1033-43. doi: 10.1111/j.1528-1167.2012.03447.x. Epub 2012 Apr 3.

15.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2. Review.

16.

Biomarkers in Alzheimer's disease.

Riverol M, López OL.

Front Neurol. 2011 Jul 14;2:46. doi: 10.3389/fneur.2011.00046. eCollection 2011.

17.

Brain MAPS: an automated, accurate and robust brain extraction technique using a template library.

Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Apr 1;55(3):1091-108. doi: 10.1016/j.neuroimage.2010.12.067. Epub 2010 Dec 31.

18.

Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, Shaw LM, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Jul 13;75(2):143-51. doi: 10.1212/WNL.0b013e3181e7ca82.

19.

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans.

Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1463-80. doi: 10.1016/j.neurobiolaging.2010.04.033.

20.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk